Section H: Treatments

Similar documents
REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS

FORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary

Drug Treatment Program Update

104 MMWR December 17, 2004

Understanding Viruses CHAPTER 38. Antiviral Agents. Understanding Viruses (cont'd) Viral Infections (cont'd) Viral Infections.

Year 2002 Paper two: Questions supplied by Jo 1

AIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010

Chapter 12. HIV Drug Glossary. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) *

20 Years of Tears and Triumphs

Prevention and Treatment of Selected Opportunistic Infections: A Guidelines Update

Recommended Comparator Products: Medicines for HIV/AIDS and Related Diseases

Review Article MANAGEMENT OF ORAL MANIFESTATIONS IN HIV/AIDS : A REVIEW. University Journal of Dental Sciences

ANTI-HIV DRUG INTERACTIONS. a guide to the interactions found between anti-hiv drugs and common hiv-related therapies

Antiviral Chemotherapy

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM

Opportunistic Infections BHIVA Guidelines

The Annotated Bibliography of the UCSF HIV Solid Organ Transplantation Project. ARV Dosing in End Stage Renal Disease

B. Incorrect! Peginterferon α-2a is used for the treatment of chronic hepatitis B and may be preferable to interferon- α.

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

Anti-viral drugs. Certain viruses multiply in the cytoplasm but others do in the nucleus Most multiplication take place before diagnosis is made

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920

Anti-viral drugs. Certain viruses multiply in the cytoplasm but others do in the nucleus Most multiplication take place before diagnosis is made

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

Antifungals, antivirals, antiprotozoals, and anthelmintics

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

HIV/AIDS 2HRS. Purpose: The purpose of this course is to provide an update on human. immunodeficiency virus and acquired immunodeficiency syndrome.

Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome. Purpose: The purpose of this course is to provide an update on human

Physiological and pharmacological factors of insomnia in HIV disease

HIV - Life cycle. HIV Life Cyle

Comprehensive Guideline Summary

6. HIV DISEASE. Steven Asch, MD, MPH

HIV / AIDS & Opportunistic Infections.

MYCOBACTERIUM AVIUM COMPLEX

medical monitoring: clinical monitoring and laboratory tests

HIV and AIDS. Shan Nanji

Viral genetics VIRAL GENETICS

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016

HIV infection. Patient information from the BMJ Group. HIV infection. What is HIV infection?

WOMEN'S INTERAGENCY HIV STUDY QUESTION BY QUESTION SPECIFICATIONS FORM 22: MEDICAL AND HEALTH HISTORY

PROGRESSIVE MULTI-FOCAL LEUKOENCEPHALOPATHY

OI prophylaxis When to start, when to stop. Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco

Division of Public Health Services Office of the Assistant Director Public Health Preparedness Services

HIV Drugs and the HIV Lifecycle

Question 1. Question 2. HIV OVERVIEW AND UPDATE 2013: What We Need Know. Presenter: Alan Keating Conyers, GA 3/2/2014

HIV for the Non-ID Pharmacist

TORONTO GENERAL HOSPITAL HIV AMBULATORY CARE ROTATION

Not just HIV: OIs and Viral Hepatitis. Wari Allison MBBS PhD Healthcare Australia (HCA)

Antiviral Drugs Lecture 5

Herpes Simplex Viruses. HSV-1 HSV-2 Herpesvirus hominis Infection mucocutaneous surfaces, CNS

1/18/2011. Handling TB and HIV. Fargo, North Dakota September 15-16, Treatment of TB in the HIV Co-Infected Patient

Total: 2.5. million East Asia & Pacific UNAIDS. Eastern Europe & Central Asia. Western Europe. North America. North Africa & Middle East

Nothing to disclose.

PROGRESS JOURNAL. Use this journal to help you keep a record of how your angina is affecting you, then share it with your cardiologist

HIV/AIDS Update 2007

The New England Journal of Medicine. Review Article

Antiviral Agents DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU. 06 August

Antiviral Therapies in Children: Has Their Time Arrived?

Chapter 5 ~ Infections

Recommended comparator products: Medicines for HIV/AIDS and related diseases

Didactic Series. Fungal Infections: small bother to big mortality

DR. SATTI A/RAHIM SATTI CONSULTANT PEDIATRICION

Ramelteon pronounced as (ram el' tee on)

PEDIATRIC HUMAN IMMUNO DEFICIENCY VIRUS. IAP UG Teaching slides

PACKAGE INSERT FOR MYCOBUTIN

Human Immunodeficiency Virus (HIV)

Current Report - HIV. Treatment of AIDS and HIV-Related Conditions

TREATMENT AND PROPHYLAXIS OF OPPORTUNISTIC INFECTIONS IN HIV (Except Mycobacterium tuberculosis)

PAEDIATRIC ANTIRETROVIRAL THERAPY FOR THE GENERAL PRACTITIONER

Concomitant antiretroviral therapy : Avifanz must be given in combination with other antiretroviral medications.

Clinical Case Scenario. HIVeEducation Workshop, Sint Maarten 2009

number Done by Corrected by Doctor Ashraf

Each Mycobutin capsule for oral administration contains 150 mg of rifabutin.

PHCP 403 by L. K. Sarki

HIV medications HIV medication and schedule plan

Principles of Antiretroviral Therapy

Toolkit on monitoring health systems strengthening MEDICAL PRODUCTS, VACCINES AND TECHNOLOGIES

Medscape's Antiretroviral Pocket Guide for the Treatment of HIV Infection

HIV Diagnosis and Management 2015 Update. Faria Farhat, MD MedStar Washington Hospital Center

HIV Update: What the Hospital-Based Provider Should Know

Quick Reference Guide to Antiretrovirals. Guide to Antiretroviral Agents

EFFECT OF COMBINATION EXPOSURE TO ZIDOVUDINE AND SULFAMETHOXAZOLE-TRIMETHOPRIM ON IMMUNE RESPONSE IN MICE AND HUMANS

Supplementary Appendix

The Hospitalized HIV+ Patient

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

OPPORTUNISTIC INFECTIONS. IAP UG Teaching slides

HIV-associated. infections? Objectives COMMON HIV- ASSOCIATED INFECTIONS

HIV Update Objectives. Epidemiology. Epidemiology, Transmission and Natural History. Transmission Risk by Exposure. Transmission 9/29/2014

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

MANUAL OF PROCEDURES (MOP)

Mycobacterial Infections and HIV

National AIDS Treatment Advocacy Project

Treatment Of AIDS And HIV-Related Conditions

Terapia antirretroviral inicial y de rescate: Utilidad actual y futura de nuevos medicamentos

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs

THE STAGING AND MEDICATION OF HIV INFECTION

Michał Karbownik Department of Pharmacology Medical University of Łódź

EFAVIRENZ ASSOCIATED STEVENS-JOHNSON SYNDROME

Transcription:

TIME THIS SECTION BEGINS RECORDED HERE TSST04H Section H: Treatments H1. Have you ever taken AZT, a protease inhibitor, or any other drugs such as those listed on this card to treat your HIV infection (HAND R CARD #17)? PROBE: Drugs for HIV infection are sometimes called antiretroviral drugs. READ IF NEEDED: Antiretroviral drugs AZT (Retrovir, Zidovudine, ZDV) ddi (Videx, Didanosine) ddc (Hivid, Zalcitabine) D4T (Zerit, Stavudine) 3TC (Lamivudine) Ritonavir (a protease inhibitor) Indinavir (Crixivan, a protease inhibitor) Saquinavir (Invirase, a protease inhibitor) Nevirapine (a non-nucleoside reverse transcriptase inhibitor) Delavirdine (a non-nucleoside reverse transcriptase inhibitor) Lovirdine (a non-nucleoside reverse transcriptase inhibitor) B04H01 YES... 1 NO... 2 SKIP TO H6 H2. What was your CD4 count when you first began taking drugs for HIV? B04H02 ENTER CD4 COUNT: H3. Over the last 6 months, which of the following drugs have you taken? CODE ALL THAT APPLY B04H03A B04H03B B04H03C B04H03D B04H03E B04H03F B04H03G B04H03H B04H03I B04H03J B04H03K B04H03L Antiretroviral drugs AZT (Retrovir, Zidovudine, ZDV) ddi (Videx, Didanosine) ddc (Hivid, Zalcitabine) D4T (Zerit, Stavudine) 3TC (Lamivudine) Ritonavir (a protease inhibitor) Indinavir (Crixivan, a protease inhibitor) Saquinavir (Invirase, a protease inhibitor) Nevirapine (a non-nucleoside reverse transcriptase inhibitor) Delavirdine (a non-nucleoside reverse transcriptase inhibitor) Lovirdine (a non-nucleoside reverse transcriptase inhibitor) DID NOT TAKE ANY IN LAST 6 MONTHS... 1 SKIP TO H6 47

H4. Over the last 6 months, on about how many days did you take only one of these drugs? B04H04 H4a. IF ONLY ONE DRUG CODED IN H3, SKIP TO H6 H5. Over the last 6 months, on about how many days did you take more than one anti-hiv drug? B04H05 NOTE: As of baseline version 11, a verification item was added for all cases with responses greater than 180 DAYS at H5. H6. Have you ever taken any drugs to treat or to prevent problems or complications due to HIV disease such as: eye disease, cold sores, shingles, herpes, PCP or AIDS pneumonia, TB or MAC, thrush or other fungal infections, immune system problems, wasting, or cancer? PROBE: We are interested in drugs such as Septra, Acyclovir, fluconazole, clarithromycin, or Megace) B04H06 YES... 1 NO... 2 SKIP TO H40 H7. Have you ever taken any anti-cmv drugs such as those listed on this card (HAND R CARD #18) to prevent or treat eye, bowel, or other CMV disease? READ IF NEEDED: Medications to treat, control, or prevent CMV Ganciclovir (DHPG, GCV) by vein Ganciclovir by mouth (Cytovene) Ganciclovir eye implants Foscarnet by vein Cidofovir (HPMPC) by vein Cidofovir (HPMPC) by injection to eye B04H07 YES... 1 NO... 2 SKIP TO H14 48

H7a. IF R DOES NOT REPORT HAVING CMV IN CLINICAL STAGE SECTION (IF MODULE 3, QUESTION C3b = 2), SKIP TO H14. H8. Why did you first take this (these) drug(s)? B04H08 TO TREAT MY CMV DISEASE WHEN I FIRST GOT IT OR DURING A FLARE UP... 1 TO KEEP ME FROM GETTING IT IN THE FIRST PLACE... 2 H9. Over the last 6 months, which of these drugs have you taken? CODE ALL THAT APPLY FROM SAME LIST ON CARD. B04H09A B04H09B B04H09C B04H09D B04H09E B04H09F B04H09G Medications to treat, control, or prevent CMV Ganciclovir (DHPG, GCV) by vein Ganciclovir by mouth (Cytovene) Ganciclovir eye implants Foscarnet by vein Cidofovir (HPMPC) by vein Cidofovir (HPMPC) by injection to eye DID NOT TAKE ANY IN LAST 6 MONTHS... 1 SKIP TO H14 H10. CAPI INSTRUCTION: SKIP H11 AND GO TO H11a IF ONLY MEDS CODED ARE EYE IMPLANTS OR INJECTION TO EYE (THAT S GANCICLOVIR EYE IMPLANTS OR CIDOFOVIR [HPMPC] BY INJECTION TO EYE). H11. Over the last 6 months, on about how many days did you take only one of these drugs? B04H11 H11a. IF ONLY ONE DRUG CODED IN H9 NOT COUNTING GANCICLOVIR EYE IMPLANTS OR CIDOFOVIR [HPMPC] BY INJECTION TO EYE, SKIP TO H12a. 49

H12. Over the last 6 months, on about how many days did you take more than one anti-cmv drug? B04H12 NOTE: In baseline Version 11, a verification item was added for all cases with responses greater than 180 DAYS at H12. H12a. CAPI INSTRUCTION: IF GANCICLOVIR (GCV) BY VEIN IS NOT CODED IN H9, SKIP TO H14 H13. Over the last 6 months, on about how many days did you take your gancyclovir (GCV) by vein? B04H13 H14. Have you ever taken any drugs such as these to treat or prevent an episode of PCP (Pneumocystis or AIDS pneumonia) or toxo (toxoplasmosis)? (HAND R CARD #19.) READ LIST IF NEEDED: Drugs to treat or prevent PCP or toxoplamosis Septra or Bactrim (TMP/SMX, Trimethoprim/Sulfamethoxazole) by vein Septra or Bactrim (TMP/SMX, Trimethoprim/Sulfamethoxazole) by mouth Pentamidine by vein Inhaled Pentamidine (AeroPent, NebuPent, PneumoPent) Dapsone Trimethoprim Trimetrexate Leucovorin Fansidar Atovaquone (Mepron, 566) Primaquine Clindamycin by mouth Clindamycin by vein B04H14 YES... 1 NO... 2 SKIP TO H19 H14a. CAPI CHECK: IF R DID NOT REPORT HAVING PCP (IF MODULE 3, QUESTION C3g = 2), SKIP TO H16). 50

H15. Why did you first take this (these) drug(s)? B04H15 TO TREAT AN EPISODE OF PNEUMONIA... 1 TO KEEP ME FROM GETTING PNEUMONIA IN THE FIRST PLACE... 2 H16. What was your CD4 count when you first began taking a drug to prevent PCP (Pneumocystis pneumonia)? B04H16B CD4 COUNT: OR B04H16A NEVER TOOK A DRUG TO PREVENT PCP... 1 H17. Over the last 6 months, which of the following drugs have you taken? CODE ALL THAT APPLY Drugs to treat or prevent PCP or toxoplamosis B04H17A Septra or Bactrim (TMP/SMX, Trimethoprim/Sulfamethoxazole) by vein B04H17B Septra or Bactrim (TMP/SMX, Trimethoprim/Sulfamethoxazole) by mouth B04H17C Pentamidine by vein B04H17D Inhaled Pentamidine (AeroPent, NebuPent, PneumoPent) B04H17E Dapsone B04H17F Trimethoprim B04H17G Trimetrexate B04H17H Leucovorin B04H17I Fansidar B04H17J Atovaquone (Mepron, 566) B04H17K Primaquine B04H17L Clindamycin by mouth B04H17M Clindamycin by vein B04H17N DID NOT TAKE ANY IN LAST 6 MONTHS... 1 SKIP TO H19 H17a. CAPI INSTRUCTION: IF ONLY INHALED OR AEROSOLIZED PENTAMIDINE CODED IN H17, SKIP TO H19. H18. Over the last 6 months, on about how many days did you take any of these drugs? B04H18 51

H19. Have you ever taken any drugs such as these to treat or prevent an episode of tuberculosis (TB) or MAC (Mycobacterium avium complex) infection? (HAND R CARD #20) READ IF NECESSARY: Medications to treat, control, or prevent MAC (Mycobacterium Avium Complex) Clarithromycin (Biaxin, Klacid) Azithromycin (Zithromax) Clofazimine (Lamprene) Ethambutol (Myambutol) Ciprofloxacin (Cipro) Rifabutin (Mycobutin) Rifampin Sparfloxacin Ethionamide (Trecator) Medications to treat, control, or prevent TB (tuberculosis) Isoniazid (INH) Rifampin Rifamate (INH/Rifampin) Ethambutol (Myambutol) Pyrazinamide (PZA) B04H19A YES... 1 NO... 2 SKIP TO H23 H20. Which disease did you take these drugs to treat or prevent? B04H20 MAC... 1 TB... 2 BOTH... 3 52

H21. Which of these drugs have you taken over the last 6 months? CODE ALL THAT APPLY B04H21A B04H21B B04H21C B04H21D B04H21E B04H21F B04H21G B04H21H B04H21I B04H21J B04H21K B04H21L B04H21M Medications to treat, control, or prevent MAC (Mycobacterium Avium Complex) Clarithromycin (Biaxin, Klacid) Azithromycin (Zithromax) Clofazimine (Lamprene) Ethambutol (Myambutol) Ciprofloxacin (Cipro) Rifabutin (Mycobutin) Rifampin Sparfloxacin Ethionamide (Trecator) Medications to treat, control, or prevent TB (tuberculosis) Isoniazid (INH) Rifampin Rifamate (INH/Rifampin) Ethambutol (Myambutol) Pyrazinamide (PZA) DID NOT TAKE ANY IN LAST 6 MONTHS... 1 SKIP TO H23 H22. Over the last 6 months, on about how many days did you take any of these drugs? B04H22 H23. Have you ever taken any drugs such as these to treat or prevent an episode of thrush, candida, crypto (cryptococcus), histo (histoplasmosis), or other fungal infection? (HAND R CARD #20A) READ IF NECESSARY: Medications to treat, control, or prevent serious fungal diseases Amphotericin (Fungazole, Ampho B) by vein Fluconazole (Diflucan) by mouth Fluconazole (Diflucan) by vein Itraconazole (Sporanox) by mouth Flucytosine (5FC, Ancobon) Clotrimazole (Mycelex) B04H23 YES... 1 NO... 2 SKIP TO H26 NOTE: In baseline versions 6-10, a NO response skipped to H29. Skip was changed to H26 as of version 11. 53

H24. Over the last 6 months, which of the following drugs have you taken? CODE ALL THAT APPLY B04H24A B04H24B B04H24C B04H24D B04H24E B04H24F B04H24G Medications to treat, control, or prevent serious fungal diseases Amphotericin (Fungazole, Ampho B) by vein Fluconazole (Diflucan) by mouth Fluconazole (Diflucan) by vein Itraconazole (Sporanox) by mouth Flucytosine (5FC, Ancobon) Clotrimazole (Mycelex) DID NOT TAKE ANY IN LAST 6 MONTHS... 1 SKIP TO H26 H25. Over the last 6 months, on about how many days did you take any of these drugs? B04H25 H26. In the last 6 months, did you take any anti-herpes drugs such as those listed on this card (HAND R CARD #21) to treat your HIV infection or to prevent cold sores, genital herpes, or shingles? READ IF NEEDED: Anti-herpes drugs Acyclovir (Zovirax) by mouth, vein, or as ointment Famciclovir (Famvir) Valacyclovir B04H26 YES... 1 NO... 2 SKIP TO H28 H27. Over the last 6 months, on about how many days did you take any of these drugs? B04H27 54

H28. CAPI INSTRUCTION: ASK H29 IF CD4 < 200, BLANK, OR UNKNOWN. ALL OTHERS SKIP TO H32. H29. Over the last 6 months, have you taken any drugs or treatments to boost your immune system or raise your blood counts such as those listed on this card? (HAND R CARD #22) READ IF NEEDED: Medications to boost the immune system, or to boost or control blood cell counts Epogen (Erythropoietin, EPO) injections Neupogen (GCSF) injections Interferon A injections GM-CSF (sargramostim, Leukine, Prokine) injections Immune Globulin (IVIG) by vein B04H29 YES... 1 NO... 2 SKIP TO H32 H30. Over the last 6 months, which of the following drugs have you taken? CODE ALL THAT APPLY B04H30A B04H30B B04H30C B04H30D B04H30E Medications to boost the immune system, or to boost or control blood cell counts Epogen (Erythropoietin, EPO) injections Neupogen (GCSF) injections Interferon A injections GM-CSF (sargramostim, Leukine, Prokine) injections Immune Globulin (IVIG) by vein H31. Over the last 6 months, on about how many days did you take only one of these drugs? B04H31 H31a. IF ONLY ONE DRUG CODED IN H30, SKIP TO H32. H31b. Over the last 6 months, on about how many days did you take more than one of these drugs? B04H31B NOTE: As of baseline version 11, a verification item was added for all cases with responses greater than 180 DAYS at H31b. 55

H32. CAPI CHECK: IF R DID NOT REPORT WASTING (A8 IS LESS THAN OR EQUAL TO.90 OF A9) OR WEIGHT LOSS THAT BOTHERED R MODERATELY OR EXTREMELY (MODULE 4) SKIP TO H39. H33. Over the last 6 months, have you taken any drugs or treatments for wasting such as those listed on this card? (HAND R CARD #23) READ IF NEEDED: Medications to treat, control, or prevent wasting or severe weight loss Megace (megestrol acetate) Marinol (dronabinol) Testosterone Growth Hormone (Serostim, HGH) Oral liquid food supplements (Ensure, or others) Parenteral nutrition (TPN, PPN, feeding by vein or central line) Thalidomide (Synovir) B04H33 YES... 1 NO... 2 SKIP TO H39 H34. Over the last 6 months, which of the following drugs or treatments have you taken? CODE ALL THAT APPLY B04H34A B04H34B B04H34C B04H34D B04H34E B04H34F B04H34G Medications to treat, control, or prevent wasting or severe weight loss Megace (megestrol acetate) Marinol (dronabinol) Testosterone Growth Hormone (Serostim, HGH) Oral liquid food supplements (Ensure, or others) Parenteral nutrition (TPN, PPN, feeding by vein or central line) Thalidomide (Synovir) H35. IF ONLY ORAL LIQUID FOOD SUPPLEMENTS BY MOUTH ARE CODED IN H34, SKIP TO H39. H36. IF PARENTERAL NUTRITION (FEEDING BY VEIN) IS NOT CODED IN H34, SKIP TO H38. 56

H37. Over the last 6 months, on about how many days did you receive parenteral nutrition or food by vein? B04H37 H38. Forgetting about food by vein or nutritional supplements by mouth for the moment, on how many days in the last 6 months did you take any of the other drugs that you mentioned? B04H38 H39. CAPI CHECK: ASK H39a. ONLY ASK IF R HAS CANCER. IF R DID NOT REPORT CANCER (IF MODULE 3, QUESTION C1e = 2 or C1f = 2), SKIP TO H40. H39a. Over the last 6 months, have you taken any treatment for KS, lymphoma or other cancer? B04H39A YES... 1 NO... 2 SKIP TO H40 H39b. Did you have: (Circle One on Each Line) Yes No B04H39B Chemotherapy?... 1 2 B04H39C Radiation?... 1 2 B04H39D Some other kind of treatment?... 1 2 H40. Over the last 6 months, have you regularly taken any drugs for depression, anxiety, or emotional problems? (SHOW R CARD #24) B04H40 YES... 1 NO... 2 SKIP TO H42 57

H41. Is it one of the drugs on this card? (SHOW CARD #24) Drugs to treat depression, anxiety, or emotional problems Fluoxetine (Prozac) Paroxetine (Paxil) Sertraline (Zoloft) Fluvoxamine (Luvox) Venlafaxine (Effexor) Nefazodone (Serzone) Clomipramine (Anafranil) Buspirone (Buspar) Prazepam (Centrax) Paxipam (Halazepam) Clozapine (Clozaril) Risperidone (Risperdal) Naltrexone (Revia) B04H41 YES... 1 NO... 2 SKIP TO H42 H41a. Over the last 6 months, on about how many days did you take any of the drugs on this card? (SHOW CARD #24) B04H41A H42. Over the last 6 months, have you taken any prescription drugs for pain? B04H42 YES... 1 NO... 2 58